Medical Devices Today

Institutional Innovation in Devices

Article preview reprinted from Start-Up - June 2008

These days, medtech investors need to be much more selective about how they spend their capital. In pursuit of steady streams of early-stage opportunities with a high likelihood of success, VCs are establishing closer ties with entprepreneurs and executives they feel can do it again. Find out what they are looking for?

Energizing the Aesthetics Market

Article preview from Medtech Insight - June 2008

Medtech Insight estimates the market for energy-based aesthetic devices will surpass the $1 billion mark by 2011. Skin resurfacing and skin tightening are the fastest growing segments--combined, they account for 36.6% of sales. At some point, more consolidation is likely in this very hot market, but for now there is still room for growth, and market drivers seem to outweigh market limiters. Find out where there's still room for growth.

Gentag and MacroArray Develop Prostate Cancer Diagnostic

Deal of the Week reprinted from Strategic Transactions - June 2008

Gentag (wireless sensors for diagnostics) and MacroArray Technologies (biomarker discovery platform) will work together to develop a wireless immunoassay for prostate cancer.

Durom: Why Zimmer's Loss Isn't Always Biomet's Gain

Full article reprinted from "The Gray Sheet" - July 21, 2008

Find out why Biomet's CEO Jeff Binder suggested his company could perhaps have done more in the U.S. to exploit the struggles of some of competitors like Zimmer's recent investigation into failures of its Durom hip implants.

FDA's June 2008 Clearances of 510(k)s

Full listing of June 2008 Clearances of 510(k)s reprinted from "The Gray Sheet" - July 21, 2008

Includes clearances for Abbott Vascular, Biomet Spine, Ethicon Endo-Surgery, Medtronic Vascular and 240 other top medical device companies. See what your competitors are doing.

Sino-U.S. To Jointly Set Up Medical Device R&D Base In Shenzhen

Chinese-language news summary reprinted from PharmAsia News - July 21, 2008

Shenzhen Institute of Advanced Technology, a branch of the Chinese Academy of Sciences, and American medical device company STI Medical Systems will jointly set up a high-level medical device R&D base in Shenzhen. Find out what their focus will be.

Senate Bill Anticipates $52.5 Million in Device User Fee Funding for FY 2009

Full brief reprinted from "The Gray Sheet' - July 21, 2008

Find out how much the FDA and CDRH stand to gain from an Agriculture bill that passed the Senate Appropriations Committee July 17.

GAO: Prior Authorization For Medicare Imaging Scans Should Be On The Table

Full article reprinted from "The Gray Sheet" - July 21, 2008

Find out why the Government Accountability Office is recommending that CMS consider adopt a gatekeeper "prior authorization" payment policy to curtail the rapid growth of Medicare spending on imaging services.

How Well Does Your Company's Medical Device Marketing Measure Up?

Sponsored announcement from Standing Stone Partners - July 2008

Does your medical device marketing message propel your business and create company value?

Successful medical device innovators realize that a well crafted Target Market Message can make all the difference in impacting the market and achieving early success. Find out how you can be more successful.

ART: Bucking the Trend in Bioabsorbable Stents

Article preview from IN VIVO - June 2008

Bioabsorbable stents arouse great enthusiasm among both interventionalists and industry executives, because they have one major advantage over current stents, both bare metal and drug-eluting: they obviate the need for a permanent implant when only a temporary scaffolding effect is needed. Many stent companies are hedging their bets, working on stents that incorporate both drug elution and bioabsorbability--but not Paris-based Arterial Remodeling Technologies, which is arguing that natural healing, not drug therapy, is the best approach to therapeutically active stents.